Finding Eden – alternative transplantation sites for pancreatic islets
Authors:
Z. Hladíková 1,2; Z. Berková 3; A. Pátíková 2,3; B. Hagerf 1,2; I. Leontovyč 3; J. Kříž 1,2; T. Marada 4; J. Froněk 4; F. Saudek 1,2
Authors place of work:
Centrum diabetologie, Institut klinické a experimentální medicíny, Praha
1; 1. lékařská fakulta, Univerzita Karlova, Praha
2; Laboratoř Langerhansových ostrůvků, Centrum experimentální medicíny, Institut klinické a experimentální medicíny, Praha
3; Klinika transplantační chirurgie, Transplantcentrum, Institut klinické a experimentální medicíny, Praha
4
Published in the journal:
Rozhl. Chir., 2022, roč. 101, č. 1, s. 14-21.
Category:
Review
doi:
https://doi.org/10.33699/PIS.2022.101.1.14–21
Summary
Pancreatic islets transplantation is an established treatment method for type 1 diabetic patients with the hypoglycemia unawareness syndrome in whom a therapy with modern technologies fails. Islet transplantation is most commonly done using an interventional radiology method: a tissue suspension of pancreatic islets is applied into a branch of the portal vein through a percutaneously installed catheter. Although being minimally invasive unlike pancreas organ transplant, this method is associated with many technical difficulties. Possible complications of the procedure include hemorrhage and portal vein thrombosis. Unlike their natural dispersed localization in exocrine pancreas, isolated pancreatic islets are exposed to hypoxia, toxins and immunosuppressive drugs in the liver parenchyma. Direct contact with the recipient’s blood causes an instant blood mediated inflammatory reaction (IBMIR) resulting in the death of more than half of the pancreatic islets shortly after their application. Therefore the size of the islet graft is often insufficient and a number of transplanted patients require administration of exogenous insulin. All of these are reasons for seeking an alternative transplantation site with more hospitable conditions for long-term islet survival. Various transplantation sites have been tested in experimental and clinical research. The advantages and disadvantages of some of them are summarized in this paper. Currently, transplantation into the greater omentum seems most promising, which has already been used in clinical practice at several institutions.
Keywords:
Transplantation – type 1 diabetes mellitus – pancreatic islets – hypoglycemia unawareness syndrome – omentum
Zdroje
1. Rickels MR, Robertson RP. Pancreatic islet transplantation in humans: Recent progress and future directions. Endocr Rev. 2019 Apr 1;40(2):631−668. doi:10.1210/ er.2018-00154.
2. Barton FB, Rickels MR, Alejandro R, et al. Improvement in outcomes of clinical islet transplantation: 1999−2010. Diabetes Care 2012 Jul;35(7):1436−1445. doi:10.2337/dc12-0063.
3. Carlsson PO, Palm F, Andersson A, et al. Markedly decreased oxygen tension in transplanted rat pancreatic islets irrespective of the implantation site. Diabetes 2001 Mar;50(3):489−495. doi:10.2337/ diabetes.50.3.489.
4. Bonner-Weir S, Orci L. New perspectives on the microvasculature of the islets of Langerhans in the rat. Diabetes 1982;31:883−889. doi:10.2337/ diab.31.10.883.
5. Smink AM, de Vos P. Therapeutic strategies for modulating the extracellular matrix to improve pancreatic islet function and survival after transplantation. Curr Diab Rep. 2018 May 19;18(7):39. doi:10.1007/s11892-018-1014-4.
6. Westermark GT, Westermark P, Berne C, et al. Widespread amyloid deposition in transplanted human pancreatic islets. N Engl J Med. 2008 Aug 28;359(9):977−979. doi:10.1056/NEJMc0802893.
7. Shapiro AM, Gallant HL, Hao EG, et al. The portal immunosuppressive storm: relevance to islet transplantation? Ther Drug Monit. 2005 Feb;27(1):35−37. doi:10.1097/00007691-200502000- 00008.
8. Johansson H, Lukinius A, Moberg L, et al. Tissue factor produced by the endocrine cells of the islets of Langerhans is associated with a negative outcome of clinical islet transplantation. Diabetes 2005 Jun;54(6):1755−1762. doi:10.2337/ diabetes.54.6.1755.
9. Eich T, Eriksson O, Lundgren T. Visualization of early engraftment in clinical islet transplantation by positron-emission tomography. New England Journal of Medicine 2007;356(26):2754−2755. doi:10.1056/NEJMc070201.
10. Delaune V, Berney T, Lacotte S, et al. Intraportal islet transplantation: the impact of the liver microenvironment. Transpl Int. 2017 Mar;30(3):227−238. doi:10.1111/ tri.12919.
11. Foster ED, Bridges ND, Feurer ID, et al. Improved health-related quality of life in a phase 3 islet transplantation trial in type 1 diabetes complicated by severe hypoglycemia. Diabetes Care 2018 May;41(5):1001−1008. doi:10.2337/dc17- 1779.
12. Bottino R, Knoll MF, Knoll CA, et al. The future of islet transplantation is now. Front Med. (Lausanne) 2018 Jul 13;5:202. doi:10.3389/fmed.2018.00202.
13. Vantyghem MC, Chetboun M, Gmyr V, et al. Ten-year outcome of islet alone or islet after kidney transplantation in type 1 diabetes: A prospective parallel-arm cohort study [published correction appears in Diabetes Care 2020 May;43(5):1164]. Diabetes Care 2019;42(11):2042−2049. doi:10.2337/dc19-0401.
14. Liljebäck H, Espes D, Carlsson PO. Unsurpassed intrahepatic islet engraftment – the quest for new sites for beta cell replacement. Cell Med. 2019 Jun 24;11. doi:10.1177/2155179019857662.
15. Ao Z, Matayoshi K, Lakey JR, et al. Survival and function of purified islets in the omental pouch site of outbred dogs. Transplantation 1993 Sep;56(3):524−529. doi:10.1097/00007890-199309000- 00007.
16. Stagner J, Ahren B, Sundler F, et al. Reconstructing the pancreas: restoration of normoglycemia, exocrine function, and islet innervation by islet transplantation to the pancreas. Transplant Proc. 2008 Mar;40(2):452−454. doi:10.1016/j. transproceed.2008.01.031.
17. Tian XH, Xue WJ, Ding XM, et al. Small intestinal submucosa improves islet survival and function during in vitro culture. World J Gastroenterol. 2005 Dec 14;11(46):7378−83. doi:10.3748/wjg.v11. i46.7378.
18. Echeverri GJ, McGrath K, Bottino R, et al. Endoscopic gastric submucosal transplantation of islets (ENDO-STI): technique and initial results in diabetic pigs. Am J Transplant. 2009 Nov;9(11):2485−2496. doi:10.1111/j.1600-6143.2009.02815.x.
19. Tchervenivanov N, Yuan S, Lipsett M, et al. Morphological and functional studies on submucosal islet transplants in normal and diabetic hamsters. Cell Transplant. 2002;11(6):529−537. PMID: 12428742.
20. Wszola M, Berman A, Gorski L, et al. Endoscopic islet autotransplantation into gastric submucosa − 1000- day follow-up of patients. Transplant Proc. 2018;50:2119–2123. doi:10.1016/j. transproceed.2018.02.138
21. Wszola M, Berman A, Ostaszewska A, et al. Islets allotransplantation into gastric submucosa in a patient with portal hypertension: 4-year follow-up. Transplant Proc. 2018 Jul-Aug;50(6):1910−1913. doi:10.1016/j.transproceed.2018.02.170.
22. Kim HI, Yu JE, Park CG, et al. Comparison of four pancreatic islet implantation sites. J Korean Med Sci. 2010 Feb;25(2):203−210. doi:10.3346/jkms.2010.25.2.203.
23. Jindal RM, Sidner RA, McDaniel HB, et al. Intraportal vs kidney subcapsular site for human pancreatic islet transplantation. Transplant Proc. 1998 Mar;30(2):398−399. doi:10.1016/s0041-1345(97)01327-4.
24. Itoh T, Nishinakamura H, Kumano K, et al. The spleen is an ideal site for inducing transplanted islet graft expansion in mice. PLoS One 2017 Jan 30;12(1):e0170899. doi:10.1371/journal.pone.0170899.
25. Ansara MF, Saudek F, Newton M, et al. Pancreatic islet transplantation prevents defective glucose counter-regulation in diabetic dogs. Transplant Proc. 1994 Apr;26(2):664−665. PMID: 8171600.
26. Kaufman DB, Morel P, Field MJ, et al. Purified canine islet autografts. Functional outcome as influenced by islet number and implantation site. Transplantation 1990 Sep;50(3):385−391. PMID: 2169662.
27. Cantarelli E, Melzi R, Mercalli A, et al. Bone marrow as an alternative site for islet transplantation. Blood 2009 Nov 12;114(20):4566−45674. doi:10.1182/ blood-2009-03-209973.
28. Salazar-Bañuelos A, Wright JR Jr, Sigalet D, et al. Pancreatic islet transplantation into the bone marrow of the rat. Am J Surg. 2008 May;195(5):674−678; discussion 678. doi: 10.1016/j.amjsurg. 2007.12.040. Erratum in: Am J Surg. 2008 Aug;196(2):313.
29. Cantarelli E, Citro A, Pellegrini S, et al. Transplant site influences the immune response after islet transplantation: Bone marrow versus liver. Transplantation 2017 May;101(5):1046−1055. doi:10.1097/ TP.0000000000001462.
30. Maffi P, Nano R, Monti P, et al. Islet allotransplantation in the bone marrow of patients with type 1 diabetes: A pilot randomized trial. Transplantation 2019 Apr;103(4):839−851. doi:10.1097/ TP.0000000000002416.
31. Kaur G, Mital P, Dufour JM. Testisimmune privilege − assumptions versus facts. Anim Reprod. 2013 Jan;10(1):3−15. PMID: 25309630.
32. Shishido A, Caicedo A, Rodriguez-Diaz R, et al. Clinical intraocular islet transplantation is not a number issue. CellR4 Repair Replace Regen Reprogram. 2016;4(4):e2120. PMID: 29497631.
33. Wang W, Gu Y, Tabata Y, et al. Reversal of diabetes in mice by xenotransplantation of a bioartificial pancreas in a prevascularized subcutaneous site. Transplantation 2002 Jan 15;73(1):122−129. doi: 10.1097/00007890-200201150-00023.
34. Patikova A, Vojtiskova A, Fabryova E, et al. The optimal maturation of subcutaneous pouch can improve pancreatic islets engraftment in rat model. Transplantation 2021 Jun 4. doi:10.1097/ TP.0000000000003844.
35. Scharp DW, Marchetti P. Encapsulated islets for diabetes therapy: history, current progress, and critical issues requiring solution. Adv Drug Deliv Rev. 2014 Apr;67-68:35−73. doi:10.1016/j. addr.2013.07.018.
36. Barkai U, Weir GC, Colton CK, et al. Enhanced oxygen supply improves islet viability in a new bioartificial pancreas. Cell Transplant. 2013;22(8):1463−1476. doi:10.3727/096368912X657341.
37. One-year follow-up safety study in subjects previously implanted with VC-01™(ClinicalTrials.gov Identifier: NCT02939118)
38. A safety, tolerability and efficacy study of Sernova‘s Cell Pouch™ for clinical islet transplantation. ClinicalTrials.gov Identifier: NCT03513939)
39. Thomas M, Moriyama K, Ledebo I. AN69: Evolution of the world‘s first high permeability membrane. Contrib Nephrol. 2011;173:119−129. doi:10.1159/000328961.
40. Lo CY. Parathyroid autotransplantation during thyroidectomy. ANZ J Surg. 2002 Dec;72(12):902−907. doi:10.1046/j.1445- 2197.2002.02580.x.
41. Stegall MD. Monitoring human islet allografts using a forearm biopsy site. Ann Transplant. 1997;2(3):8−11. PMID: 9869858.
42. Stegall MD, Lafferty KJ, Kam I, et al. Evidence of recurrent autoimmunity in human allogeneic islet transplantation. Transplantation 1996 Apr 27;61(8):1272-4. doi:10.1097/00007890-199604270-00027.
43. Christoffersson G, Henriksnäs J, Johansson L, et al. Clinical and experimental pancreatic islet transplantation to striated muscle: Establishment of a vascular system similar to that in native islets. Diabetes 2010;59:2569–2578. doi:10.2337/ db10-0205.
44. Rafael E, Tibell A, Rydén M, et al. Intramuscular autotransplantation of pancreatic islets in a 7-year-old child: a 2-year follow-up. Am J Transplant. 2008 Feb;8(2):458−462. doi:10.1111/j.1600- 6143.2007.02060.x.
45. Yasunami Y, Lacy PE, Finke EH. A new site for islet transplantation − a peritoneal- omental pouch. Transplantation 1983 Aug;36(2):181−182. doi:10.1097/00007890-198308000- 00014.
46. Schaschkow A, Mura C, Pinget M, et al. Intra-omental islet transplantation using h-omental matrix islet filliNG (hOMING). J Vis Exp. 2019 Mar 14;(145). doi:10.3791/58898.
47. Kriz J, Vilk G, Mazzuca DM, et al. A novel technique for the transplantation of pancreatic islets within a vascularized device into the greater omentum to achieve insulin independence. Am J Surg. 2012 Jun;203(6):793−797. doi:10.1016/j.amjsurg. 2011.02.009.
48. Berman DM, Molano RD, Fotino C, et al. Bioengineering the endocrine pancreas: Intraomental islet transplantation within a biologic resorbable scaffold. Diabetes 2016 May;65(5):1350−1361. doi:10.2337/ db15-1525.
49. Berman DM, O‘Neil JJ, Coffey LC, et al. Long-term survival of nonhuman primate islets implanted in an omental pouch on a biodegradable scaffold. Am J Transplant. 2009 Jan;9(1):91−104. doi:10.1111/j.1600-6143.2008.02489.x.
50. Baidal D, Berman DM, Ricordi C, et al. Stable graft function and glycemic control after clinical islet transplantation on the omentum. Diabetes 2019 Jun; 68 (Supplement 1) 259−LB; doi:10.2337/db19- 259-LB.
51. Hladíková Z, Voglová B, Pátíková A, et al. Bioluminescence imaging in vivo confirms the viability of pancreatic islets transplanted into the greater omentum. Mol Imaging Biol. 2021 Feb 18. doi:10.1007/s11307-021-01588-y.
52. Saudek F, Hladíková Z, Hagerf B, et al. Islet transplantation into the omentum using a biocompatible plasma-thrombin gel: experience at the Institute for Clinical and Experimental Medicine in Prague. IPITA, Virtual, October 20−23, 2021. P.105. https://app.ipita2021.org/virtual/lecture/ 200.
53. Guo Y, Wu C, Xu L, et al. Vascularization of pancreatic decellularized scaffold with endothelial progenitor cells. J Artif Organs 2018 Jun;21(2):230−237. doi:10.1007/s10047-018-1017-6.
54. Cito M, Pellegrini S, Piemonti L, et al. The potential and challenges of alternative sources of β cells for the cure of type 1 diabetes. Endocr Connect. 2018 Mar;7(3):R114−R125. doi:10.1530/EC-18- 0012.
55. Parnaud G, Hammar E, Ribaux P, et al. Signaling pathways implicated in the stimulation of beta-cell proliferation by extracellular matrix. Mol Endocrinol. 2009 Aug;23(8):1264−1271. doi:10.1210/ me.2009-0008.
56. Napierala H, Hillebrandt KH, Haep N, et al. Engineering an endocrine neo-pancreas by repopulation of a decellularized rat pancreas with islets of Langerhans. Sci Rep. 2017 Feb 2;7:41777. doi:10.1038/ srep41777.
57. Kasoju N, Pátíková A, Wawrzynska E, et al. Bioengineering a pre-vascularized pouch for subsequent islet transplantation using VEGF-loaded polylactide capsules. Biomater Sci. 2020 Jan 21;8(2):631−647. doi: 10.1039/c9bm01280j. Erratum in: Biomater Sci. 2019 Dec 12.
58. Koblas T, Leontovyč I, Zacharovová K, et al. Activation of the Jak/Stat signalling pathway by leukaemia inhibitory factor stimulates trans-differentiation of human non-endocrine pancreatic cells into insulin- producing cells. Folia Biol. (Praha) 2012;58(3):98−105. PMID: 22849859.
59. Othonos N, Choudhary P. Who should be considered for islet transplantation alone? Curr Diab Rep. 2017 Apr;17(4):23. doi: 10.1007/s11892-017-0847-6. Erratum in: Curr Diab Rep. 2017 Apr;17 (4):29.
Štítky
Surgery Orthopaedics Trauma surgeryČlánok vyšiel v časopise
Perspectives in Surgery
2022 Číslo 1
- Metamizole at a Glance and in Practice – Effective Non-Opioid Analgesic for All Ages
- Metamizole vs. Tramadol in Postoperative Analgesia
- Spasmolytic Effect of Metamizole
Najčítanejšie v tomto čísle
- High resolution anorectal manometry in patients with anorectal dysfunctions and the therapeutic consequences
- Incarcerated left paraduodenal hernia − case report and literature review
- Successful repeated gastric peroral endoscopic myotomy (re-G-POEM) in the treatment of postsurgical gastroparesis
- Endoscopic management of gastrointestinal motility disorders